"The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of selexipag (Uptravi, Actelion Registration Ltd) for the treatment of adults with pulmonary arterial hypertension (PAH)./"...
Beta-adrenoreceptor blockade can cause reduction of intraocular pressure. Patients should be told that Inderide (propranolol hydrochloride and hydrochlorothiazide) may interfere with the glaucoma screening test. Withdrawal may lead to a return of increased intraocular pressure.
Last reviewed on RxList: 5/13/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Inderide Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on handling your hypertension.